MedPath

Effect of Compression Garments on Exercise Performance Following Acute High Intensity Exercise

Not Applicable
Completed
Conditions
Muscle Damage
Interventions
Other: Spandex
Other: Far Infrared Fabric
Registration Number
NCT02076334
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

To examine the influence of compression garments manufactured with Far-Infrared technology on exercise performance during and after repeated eccentric isokinetic muscle actions of the leg extensors.

Detailed Description

Participants: Eighty recreationally active (1-5 hrs per week) healthy participants between the ages of 18 - 35 will visit the Neuromuscular Research Laboratory on 6 separate occasions, with 4 of those occasions also requiring a visit to Health services for a blood draw.

Procedures (methods): During pre-screening, each participant will complete an informed consent document, a health history questionnaire, and have their stature and body mass assessed. A familiarization session will then be conducted on a separate day where all participants will practice the strength assessment, eccentric isokinetic protocol, and ultrasound assessments. Participants will be assigned to 1 of the 4 treatment groups based on their initial maximal isometric strength values using a matched-participants design. The first experimental session will then begin 2-10 days later, where the participants will perform the repeated eccentric exercise protocol (10 sets of 15 eccentric contractions 210 deg/sec with 3 min of rest between sets) with the non-dominant leg following a 60 min rest period where they will wear the apparel and perform a 5 min warm-up on a cycle ergometer. Follow-up blood draws and strength and ultrasound assessments will be obtained at 24 and 48 hours post-exercise. Each participant will also complete a visual analog scale at baseline, 24, 48, and 72 hours post-exercise to examine perceived muscle soreness.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • Cohort of Adult Males & Females
  • Participant is between the ages of 18-35
  • Healthy, Recreationally Active (1-5 hours per week)
  • Participant has provided written and dated informed consent to participate in the study
  • Participant is apparently healthy and free from disease, as determined by a health history questionnaire
  • Participant agrees to abstain from smoking, caffeine (4hrs prior), tobacco (24hrs prior), and alcohol (24 hrs) before testing days
  • Participant agrees to abstain from exercise 24 hours prior to each testing visit and after 72 hours of the induced exercise damage
  • Participant will refrain from the use of non-steroidal anti-inflammatory drugs (NSAIDs) and protein supplementation 24 hours before the exercise testing protocol, as well as for the 72 hour period following the exercise testing protocol.
Exclusion Criteria
  • Participant is using, or has used one of the following dietary supplements within 12 weeks prior to enrollment: beta-alanine, creatine, taurine, or any supplemental antioxidants (Acai, pomegranate, beet juice).
  • Participant is in, or has participated in another clinical trial within 6 weeks prior to enrollment
  • Participant has a known allergy or sensitivity to test product (determined from health history questionnaire and consent form)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Normal Garment + normal garmentSpandexSpandex during exercise + Spandex at night
Normal Garment + Test garment at nightFar Infrared FabricSpandex during exercise + Far Infrared Fabric at night
Compression + normal garmentFar Infrared FabricFar Infrared Fabric during exercise + Spandex at night
Compression + normal garmentSpandexFar Infrared Fabric during exercise + Spandex at night
Test garment + Test garmentFar Infrared FabricFar Infrared Fabric during exercise + Far Infrared Fabric at night
Normal Garment + Test garment at nightSpandexSpandex during exercise + Far Infrared Fabric at night
Primary Outcome Measures
NameTimeMethod
Maximal Voluntary Contraction (MVC)up to 72 hours
Secondary Outcome Measures
NameTimeMethod
Creatine Kinasebaseline, 24 hrs and 48 hrs post

Trial Locations

Locations (1)

Exercise and Sport Science (University of North Carolina)

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath